Catalyst Pharmaceuticals https://www.reuters.com/markets/companies/CPRX.O” target=”_blank” rel=”noopener”>(CPRX.O) said on Thursday that U.S. health regulators have approved its partner Santhera Pharmaceuticals’ https://www.reuters.com/markets/companie???
Read More
About The Author
